참고문헌 (56)

1. Holohan C , Van Schaeybroeck S , Longley DB , Johnston PG . Cancer drug resistance: an evolving paradigm . Nat Rev Cancer . 2013 ; 13 : 714 ‐ 726 . 

   상세보기

2. Assmus HE , Herwig R , Cho KH , Wolkenhauer O . Dynamics of biological systems: role of systems biology in medical research . Expert Rev Mol Diagn . 2006 ; 6 : 891 ‐ 902 . 

   상세보기

3. Schmidt H , Cho KH , Jacobsen EW . Identification of small scale biochemical networks based on general type system perturbations . FEBS J . 2005 ; 272 : 2141 ‐ 2151 . 

   상세보기

4. Kim JR , Kim J , Kwon YK , Lee HY , Heslop‐Harrison P , Cho KH . Reduction of complex signaling networks to a representative kernel . Sci Signal . 2011 ; 4 : ra35 . 

   상세보기

5. Kim JR , Cho KH . The multi‐step phosphorelay mechanism of unorthodox two‐component systems in E. coli realizes ultrasensitivity to stimuli while maintaining robustness to noises . Comput Biol Chem . 2006 ; 30 : 438 ‐ 444 . 

6. Siegel RL , Miller KD , Fedewa SA , et al. Colorectal cancer statistics, 2017 . CA Cancer J Clin . 2017 ; 67 : 177 ‐ 193 . 

7. Sever R , Brugge JS . Signal transduction in cancer . Cold Spring Harb Perspect Med . 2015 ; 5 : 1 – 21 . 

8. Thorpe LM , Yuzugullu H , Zhao JJ . PI3K in cancer: divergent roles of isoforms, modes of activation and therapeutic targeting . Nat Rev Cancer . 2015 ; 15 : 7 ‐ 24 . 

   상세보기

9. Fruman DA , Rommel C . PI3K and cancer: lessons, challenges and opportunities . Nat Rev Drug Discov . 2014 ; 13 : 140 ‐ 156 . 

10. Paplomata E , O'Regan R . The PI3K/AKT/mTOR pathway in breast cancer: targets, trials and biomarkers . Ther Adv Med Oncol . 2014 ; 6 : 154 ‐ 166 . 

    상세보기

11. Janku F , Yap TA , Meric‐Bernstam F . Targeting the PI3K pathway in cancer: are we making headway? Nat Rev Clin Oncol . 2018 ; 15 : 273 ‐ 291 . 

    상세보기

12. Britschgi A , Andraos R , Brinkhaus H , et al. JAK2/STAT5 inhibition circumvents resistance to PI3K/mTOR blockade: a rationale for cotargeting these pathways in metastatic breast cancer . Cancer Cell . 2012 ; 22 : 796 ‐ 811 . 

    상세보기

13. Chandarlapaty S , Sawai A , Scaltriti M , et al. AKT inhibition relieves feedback suppression of receptor tyrosine kinase expression and activity . Cancer Cell . 2011 ; 19 : 58 ‐ 71 . 

    상세보기

14. Ilic N , Utermark T , Widlund HR , Roberts TM . PI3K‐targeted therapy can be evaded by gene amplification along the MYC‐eukaryotic translation initiation factor 4E (eIF4E) axis . Proc Natl Acad Sci USA . 2011 ; 108 : E699 ‐ E708 . 

15. Serra V , Eichhorn PJ , Garcia‐Garcia C , et al. RSK3/4 mediate resistance to PI3K pathway inhibitors in breast cancer . J Clin Invest . 2013 ; 123 : 2551 ‐ 2563 . 

    상세보기

16. Wiegering A , Uthe FW , Jamieson T , et al. Targeting translation initiation bypasses signaling crosstalk mechanisms that maintain high MYC levels in colorectal Cancer . Cancer Discov . 2015 ; 5 : 768 ‐ 781 . 

    상세보기

17. Buchanan CM , Lee KL , Shepherd PR . For better or worse: the potential for dose limiting the on‐target toxicity of PI 3‐kinase inhibitors . Biomolecules . 2019 ; 9 : 1 – 26 . 

18. Zhang Y , Yan H , Xu Z , Yang B , Luo P , He Q . Molecular basis for class side effects associated with PI3K/AKT/mTOR pathway inhibitors . Expert Opin Drug Metab Toxicol . 2019 ; 15 : 767 ‐ 774 . 

19. Engelman JA . Targeting PI3K signalling in cancer: opportunities, challenges and limitations . Nat Rev Cancer . 2009 ; 9 : 550 ‐ 562 . 

    상세보기

20. Filippakopoulos P , Knapp S . Targeting bromodomains: epigenetic readers of lysine acetylation . Nat Rev Drug Discov . 2014 ; 13 : 337 ‐ 356 . 

21. Stratikopoulos EE , Dendy M , Szabolcs M , et al. Kinase and BET inhibitors together clamp inhibition of PI3K signaling and overcome resistance to therapy . Cancer Cell . 2015 ; 27 : 837 ‐ 851 . 

    상세보기

22. Stathis A , Bertoni F . BET proteins as targets for anticancer treatment . Cancer Discov . 2018 ; 8 : 24 ‐ 36 . 

    상세보기

23. Shu S , Polyak K . BET Bromodomain proteins as Cancer therapeutic targets . Cold Spring Harb Symp Quant Biol . 2016 ; 81 : 123 ‐ 129 . 

24. Alqahtani A , Choucair K , Ashraf M , et al. Bromodomain and extra‐terminal motif inhibitors: a review of preclinical and clinical advances in cancer therapy . Future Sci OA . 2019 ; 5 : FSO372 . 

25. Maira SM , Stauffer F , Brueggen J , et al. Identification and characterization of NVP‐BEZ235, a new orally available dual phosphatidylinositol 3‐kinase/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity . Mol Cancer Ther . 2008 ; 7 : 1851 ‐ 1863 . 

    상세보기

26. Roper J , Richardson MP , Wang WV , et al. The dual PI3K/mTOR inhibitor NVP‐BEZ235 induces tumor regression in a genetically engineered mouse model of PIK3CA wild‐type colorectal cancer . PLoS One . 2011 ; 6 : e25132 . 

    상세보기

27. Hanahan D , Weinberg RA . Hallmarks of cancer: the next generation . Cell . 2011 ; 144 : 646 ‐ 674 . 

    상세보기

28. Campisi J . Aging, cellular senescence, and cancer . Annu Rev Physiol . 2013 ; 75 : 685 ‐ 705 . 

    상세보기

29. Perez‐Mancera PA , Young AR , Narita M . Inside and out: the activities of senescence in cancer . Nat Rev Cancer . 2014 ; 14 : 547 ‐ 558 . 

    상세보기

30. Muranen T , Selfors LM , Hwang J , et al. ERK and p38 MAPK activities determine sensitivity to PI3K/mTOR inhibition via regulation of MYC and YAP . Cancer Res . 2016 ; 76 : 7168 ‐ 7180 . 

    상세보기

31. Juvekar A , Hu H , Yadegarynia S , et al. Phosphoinositide 3‐kinase inhibitors induce DNA damage through nucleoside depletion . Proc Natl Acad Sci USA . 2016 ; 113 : E4338 ‐ E4347 . 

    상세보기

32. Xu Y , Li N , Xiang R , Sun P . Emerging roles of the p38 MAPK and PI3K/AKT/mTOR pathways in oncogene‐induced senescence . Trends Biochem Sci . 2014 ; 39 : 268 ‐ 276 . 

    상세보기

33. Mathew R , Karantza‐Wadsworth V , White E . Role of autophagy in cancer . Nat Rev Cancer . 2007 ; 7 : 961 ‐ 967 . 

    상세보기

34. Levy JMM , Towers CG , Thorburn A . Targeting autophagy in cancer . Nat Rev Cancer . 2017 ; 17 : 528 ‐ 542 . 

    상세보기

35. Demaria M , O'Leary MN , Chang J , et al. Cellular senescence promotes adverse effects of chemotherapy and Cancer relapse . Cancer Discov . 2017 ; 7 : 165 ‐ 176 . 

    상세보기

36. Chakradeo S , Elmore LW , Gewirtz DA . Is senescence reversible? Curr Drug Targets . 2016 ; 17 : 460 ‐ 466 . 

    상세보기

37. Chitikova ZV , Gordeev SA , Bykova TV , Zubova SG , Pospelov VA , Pospelova TV . Sustained activation of DNA damage response in irradiated apoptosis‐resistant cells induces reversible senescence associated with mTOR downregulation and expression of stem cell markers . Cell Cycle . 2014 ; 13 : 1424 ‐ 1439 . 

    상세보기

38. Wang Q , Wu PC , Dong DZ , et al. Polyploidy road to therapy‐induced cellular senescence and escape . Int J Cancer . 2013 ; 132 : 1505 ‐ 1515 . 

    상세보기

39. Tchkonia T , Zhu Y , van Deursen J , Campisi J , Kirkland JL . Cellular senescence and the senescent secretory phenotype: therapeutic opportunities . J Clin Invest . 2013 ; 123 : 966 ‐ 972 . 

    상세보기

40. Christopoulos PF , Msaouel P , Koutsilieris M . The role of the insulin‐like growth factor‐1 system in breast cancer . Mol Cancer . 2015 ; 14 : 43 . 

    상세보기

41. Werner H , Sarfstein R . Transcriptional and epigenetic control of IGF1R gene expression: implications in metabolism and cancer . Growth Horm IGF Res . 2014 ; 24 : 112 ‐ 118 . 

42. Brandt B , Meyer‐Staeckling S , Schmidt H , Agelopoulos K , Buerger H . Mechanisms of EGFR gene transcription modulation: relationship to cancer risk and therapy response . Clin Cancer Res . 2006 ; 12 : 7252 ‐ 7260 . 

    상세보기

43. Purow BW , Sundaresan TK , Burdick MJ , et al. Notch‐1 regulates transcription of the epidermal growth factor receptor through p53 . Carcinogenesis . 2008 ; 29 : 918 ‐ 925 . 

    상세보기

44. Wang H , Zhang L , Yang X , et al. PUMA mediates the combinational therapy of 5‐FU and NVP‐BEZ235 in colon cancer . Oncotarget . 2015 ; 6 : 14385 ‐ 14398 . 

    상세보기

45. Ma Y , Wang L , Neitzel LR , Loganathan SN , Tang N , Qin L , Crispi EE , Guo Y , Knapp S , Beauchamp RD , Lee E , Wang J. The MAPK Pathway regulates intrinsic resistance to BET inhibitors in colorectal Cancer . Clin Cancer Res 2017 ; 23 : 2027 – 2037 . 

46. McCleland ML , Mesh K , Lorenzana E , et al. CCAT1 is an enhancer‐templated RNA that predicts BET sensitivity in colorectal cancer . J Clin Invest . 2016 ; 126 : 639 ‐ 652 . 

    상세보기

47. Lee J , Cacalano G , Camerato T , Toy K , Moore MW , Wood WI . Chemokine binding and activities mediated by the mouse IL‐8 receptor . J Immunol . 1995 ; 155 : 2158 ‐ 2164 . 

    상세보기

48. Nomiyama H , Osada N , Yoshie O . The evolution of mammalian chemokine genes . Cytokine Growth Factor Rev . 2010 ; 21 : 253 ‐ 262 . 

49. Gatla HR , Zou Y , Uddin MM , et al. Histone deacetylase (HDAC) inhibition induces IkappaB kinase (IKK)‐dependent Interleukin‐8/CXCL8 expression in ovarian cancer cells . J Biol Chem . 2017 ; 292 : 5043 ‐ 5054 . 

50. Cancer Genome Atlas Research Network , Weinstein JN , Collisson EA , et al. The Cancer Genome Atlas pan‐Cancer analysis project . Nat Genet . 2013 ; 45 : 1113 ‐ 1120 . 

    상세보기

51. Uhlen M , Oksvold P , Fagerberg L , et al. Towards a knowledge‐based human protein Atlas . Nat Biotechnol . 2010 ; 28 : 1248 ‐ 1250 . 

    상세보기

52. Ahuja N , Sharma AR , Baylin SB . Epigenetic therapeutics: a new weapon in the war against Cancer . Annu Rev Med . 2016 ; 67 : 73 ‐ 89 . 

    상세보기

53. Loganathan SN , Tang N , Holler AE , Wang N , Wang J . Targeting the IGF1R/PI3K/AKT pathway sensitizes Ewing sarcoma to BET Bromodomain inhibitors . Mol Cancer Ther . 2019 ; 18 : 929 ‐ 936 . 

    상세보기

54. Risom T , Langer EM , Chapman MP , et al. Differentiation‐state plasticity is a targetable resistance mechanism in basal‐like breast cancer . Nat Commun . 2018 ; 9 : 3815 . 

    상세보기

55. Derenzini E , Mondello P , Erazo T , et al. BET inhibition‐induced GSK3beta feedback enhances lymphoma vulnerability to PI3K inhibitors . Cell Rep . 2018 ; 24 : 2155 ‐ 2166 . 

56. Nardella C , Clohessy JG , Alimonti A , Pandolfi PP . Pro‐senescence therapy for cancer treatment . Nat Rev Cancer . 2011 ; 11 : 503 ‐ 511 . 

    상세보기

활용도 Top5 논문

더보기

해당 논문의 주제분야에서 활용도가 높은 상위 5개 콘텐츠를 보여줍니다.
더보기 버튼을 클릭하시면 더 많은 관련자료를 살펴볼 수 있습니다.